In 2009 was created Steadview Capital, which is appeared as VC. The venture was found in Asia in Hong Kong. The main office of represented VC is situated in the Hong Kong.
The overall number of key employees were 2.
The fund has exact preference in some founders of portfolio startups. In case when startup counts 1 or 3 of the founder, the chance for it to get the investment is meager. For fund there is no match between the location of its establishment and the land of its numerous investments - India. We can highlight the next thriving fund investment areas, such as Commercial Insurance, Classifieds. Among the most popular portfolio startups of the fund, we may highlight Flipkart, Olacabs, PolicyBazaar. Moreover, a startup needs to be at the age of 11-15 years to get the investment from the fund.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Steadview Capital, startups are often financed by SAIF Partners, Sequoia Capital India, Kalaari Capital. The meaningful sponsors for the fund in investment in the same round are Sequoia Capital India, SAIF Partners, ABG Capital. In the next rounds fund is usually obtained by Tiger Global Management, Sequoia Capital India, SAIF Partners.
Opposing the other organizations, this Steadview Capital works on 10 percentage points less the average amount of lead investments. The average startup value when the investment from Steadview Capital is more than 1 billion dollars. The real fund results show that this VC is 24 percentage points more often commits exit comparing to other companies. The fund is generally included in 2-6 deals every year. The common things for fund are deals in the range of more than 100 millions dollars. The important activity for fund was in 2019. The increased amount of exits for fund were in 2018.
Related Funds
Funds with similar focus
Fund Name | Location |
American Skandia | - |
Antong Holdings | China, Fujian, Quanzhou |
First Light Ventures | Atlanta, Georgia, United States |
Genkai Capital | Japan, Tokyo |
K11 Investment | China, Hong Kong, Hong Kong Island |
Kao Corporation | Japan, Tokyo |
Maton Ventures | California, Cupertino, United States |
Matthew Pritzker Company | Chicago, Illinois, United States |
Quansheng Investment | - |
Shandong Gold Group | China, Jinan, Shandong |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Ethereal Machines | $14M | 13 Jun 2024 | Bengaluru, Karnataka, India | ||
Ultrahuman | $25M | 20 Mar 2024 | Bengaluru, Karnataka, India | ||
Atomberg Technology | $86M | 29 May 2023 | Mumbai, Maharashtra, India | ||
Mayhem Studios | $20M | 11 Apr 2023 | Bengaluru, Karnataka, India | ||
Precision Neuroscience | $41M | 25 Jan 2023 | New York, New York, United States | ||
Observe.AI | $125M | 12 Apr 2022 | San Francisco, California, United States | ||
FTX US | $400M | 26 Jan 2022 | San Francisco, California, United States | ||
GlobalBees | $110M | 28 Dec 2021 | Delhi, Delhi, India | ||
Ultrahuman | $17M | 16 Aug 2021 | Bengaluru, Karnataka, India |
– Ultrahuman, a Bengaluru, India-based healthtech wearable glucose tracker, raised $17.5m in Series B funding.
– The round was led by Alpha Wave Incubation (AWI), Steadview Capital, Nexus Venture Partners, Blume Ventures and Utsav Somani’s iSeed fund, as well as Tiger Global’s Scott Schleifer, Sandeep Singhal, Kunal Shah, Sujeet Kumar, Deepinder Goyal, Gunjan Patidar, Gaurav Munjal, Revant Bhate, Mohit Gupta, Vikram Dhingra and Roman Saini.
– The company intends to use the funds for geographical expansion and improvement of its biomarker technology.
– Innovaccer has raised $1.3bn in a Series D funding round led by Tiger Global Management and bringing the total capital raised to over $225m.
– The round was also participated by existing investors Steadview Capital, Dragoneer, B Capital Group, Mubadala Capital, and M12 (Microsoft’s Venture Fund) as well as new investor OMERS Growth Equity.
– Innovaccer is on a mission to help healthcare organizations care as one.
– With its Data Activation Platform, Innovaccer connects healthcare data across a myriad of systems and settings, delivering unified patient records and actionable insights that result in better patient outcomes and lower costs.
– The company’s platform improves efficiencies for providers, payers, and others across the care ecosystem and helps them deliver whole-person care.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Ethereal Machines | $14M | 13 Jun 2024 | Bengaluru, Karnataka, India | ||
Ultrahuman | $25M | 20 Mar 2024 | Bengaluru, Karnataka, India | ||
Atomberg Technology | $86M | 29 May 2023 | Mumbai, Maharashtra, India | ||
Mayhem Studios | $20M | 11 Apr 2023 | Bengaluru, Karnataka, India | ||
Precision Neuroscience | $41M | 25 Jan 2023 | New York, New York, United States | ||
Observe.AI | $125M | 12 Apr 2022 | San Francisco, California, United States | ||
FTX US | $400M | 26 Jan 2022 | San Francisco, California, United States | ||
GlobalBees | $110M | 28 Dec 2021 | Delhi, Delhi, India | ||
Ultrahuman | $17M | 16 Aug 2021 | Bengaluru, Karnataka, India |